Biopharmaceutical company AbbVie has reached an agreement with the Trump administration to invest $100 billion in its U.S. operations
Biopharmaceutical company AbbVie has reached an agreement with the Trump administration to invest $100 billion in its U.S. operations
AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, jobs, and production of next-generation medicines.
The American Bazaar is a publication of American Bazaar, Inc., based in Germantown, MD.
